Singh Virmeet V., Toskes Phillip P.
Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Florida, PO Box 100214, Gainesville, FL 32610-0214, USA.
Curr Treat Options Gastroenterol. 2004 Feb;7(1):19-28. doi: 10.1007/s11938-004-0022-4.
Small bowel bacterial overgrowth (SBBO) syndrome is associated with excessive numbers of bacteria in the proximal small intestine. The pathology of this condition involves competition between the bacteria and the human host for ingested nutrients. This competition leads to intraluminal bacterial catabolism of nutrients, often with production of toxic metabolites and injury to the enterocyte. A complex array of clinical symptoms ensues, resulting in chronic diarrhea, steatorrhea, macrocytic anemia, weight loss, and less commonly, protein-losing enteropathy. Therapy is targeted at correction of underlying small bowel abnormalities that predispose to SBBO and appropriate antibiotic therapy. The symptoms and signs of SBBO can be reversed with this approach.
小肠细菌过度生长(SBBO)综合征与近端小肠中细菌数量过多有关。这种情况的病理涉及细菌与人体宿主对摄入营养物质的竞争。这种竞争导致肠腔内营养物质的细菌分解代谢,常常产生有毒代谢产物并损伤肠上皮细胞。随之而来的是一系列复杂的临床症状,导致慢性腹泻、脂肪泻、大细胞性贫血、体重减轻,较少见的还有蛋白丢失性肠病。治疗的目标是纠正易引发SBBO的潜在小肠异常,并进行适当的抗生素治疗。采用这种方法,SBBO的症状和体征可以得到逆转。